Antibodies to the amino-terminal domain of desmoglein 1 are retained during transition from pemphigus vulgaris to pemphigus foliaceus

被引:0
|
作者
Agustín España
Hiroshi Koga
Ricardo Suárez-Fernández
Chika Ohata
Norito Ishii
Isabel Irarrazaval
Kwesi Teye
Bungo Ohyama
Takashi Hashimoto
机构
[1] University of Navarra,Department of Dermatology, University Clinic of Navarra
[2] Kurume University School of Medicine,Department of Dermatology
[3] Universidad Autónoma de Madrid,Department of Dermatology, Gregorio Marañón Hospital
来源
关键词
acantholysis; desmoglein; desmoglein domain-swapped molecules; immunoblotting/immunoprecipitation; pemphigus foliaceus; pemphigus vulgaris;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:174 / 179
页数:5
相关论文
共 50 条
  • [21] THE EXTRACELLULAR AMINOTERMINAL DOMAIN OF BOVINE DESMOGLEIN-1 (DSG1) IS RECOGNIZED ONLY BY CERTAIN PEMPHIGUS-FOLIACEUS SERA, WHEREAS ITS INTRACELLULAR DOMAIN IS RECOGNIZED BY BOTH PEMPHIGUS-VULGARIS AND PEMPHIGUS-FOLIACEUS SERA
    DMOCHOWSKI, M
    HASHIMOTO, T
    AMAGAI, M
    KUDOH, J
    SHIMIZU, N
    KOCH, PJ
    FRANKE, WW
    NISHIKAWA, T
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 103 (02) : 173 - 177
  • [22] Avidity of anti-desmoglein antibodies in patients with pemphigus vulgaris (PV) and pemphigus foliaceus (PF) does not correlate with disease activity or clinical improvement
    Hassan, K. M.
    Streilein, R. D.
    Hall, R. P.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 : S16 - S16
  • [23] Genetic restriction of anti-desmoglein (Dsg) 1 antibodies in pemphigus foliaceus (PF)
    Ishii, K.
    Li, H.
    Lin, C.
    Kacir, S.
    Amagai, M.
    Siegel, D. L.
    Stanley, J. R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 26 - 26
  • [24] Combination of pemphigus foliaceus IgG monoclonal antibodies (mAbs) promotes desmoglein 1 clustering
    Yoshida, K.
    Ishii, K.
    Shimizu, A.
    Yokouchi, M.
    Stanley, J. R.
    Ishiko, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 : S87 - S87
  • [25] Shift in the profile of antibodies against desmoglein 3 and 1 with time in pemphigus vulgaris
    Weitz, D
    Jiao, D
    Bystryn, J
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) : A119 - A119
  • [26] Differences in epitopes of non-pathogenic autoantibodies to desmoglein1 in pemphigus foliaceus in comparison with those in pemphigus vulgaris and rheumatoid arthritis
    Aoyama, Y.
    Kamiya, K.
    Yamasaki, O.
    Shirafuji, Y.
    Hamada, T.
    Morizane, S.
    Fujii, K.
    Kubo, A.
    Iwatsuki, K.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 : S10 - S10
  • [27] Production of human monoclonal antibodies to desmoglein 3 from pemphigus vulgaris patient
    Bhol, K
    Ahmed, A
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (02) : 459 - 459
  • [28] Pemphigus foliaceus with circulating antibodies directed against desmoglein-1 and BP 230 antigen
    Wozniak, K.
    Rogozinski, T.
    Hashimoto, T.
    Kowalewski, C.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 25 - 25
  • [29] AUTOANTIBODIES AGAINST THE AMINO-TERMINAL CADHERIN-LIKE BINDING DOMAIN OF PEMPHIGUS-VULGARIS ANTIGEN ARE PATHOGENIC
    AMAGAI, M
    KARPATI, S
    PRUSSICK, R
    KLAUSKOVTUN, V
    STANLEY, JR
    JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (03): : 919 - 926
  • [30] Autoreactive T cell response against a polymorphous domain of desmoglein 1, in patients with pemphigus foliaceus
    Kupfer, I
    Martel, P
    Gilbert, D
    Drouot, L
    Chan, P
    Joly, P
    Tron, F
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (03) : 523 - 523